Aldeyra Therapeutics Stock (NASDAQ:ALDX), Quotes and News Summary

Q: What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aldeyra Therapeutics Stock (NASDAQ: ALDX) stock price, news, charts, stock research, profile.

Open	$4.050
Close	$3.940
Volume / Avg.	329.887K / 569.959K
Day Range	3.930 - 4.095
52 Wk Range	1.420 - 11.970
Market Cap	$234.093M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	4.79%
Days to Cover	2.16

Recent News

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study

Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in

Vandana Singh

FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study

The FDA issued a complete response letter to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) New Drug Application (NDA) of reproxalap, an investigational drug

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aldeyra Therapeutics (ALDX) stock?

You can purchase shares of Aldeyra Therapeutics (NASDAQ: ALDX) through any online brokerage.

View our list of the best stock brokerages.

Who are Aldeyra Therapeutics's (ALDX) competitors?

Other companies in Aldeyra Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC) and Design Therapeutics (NASDAQ:DSGN).

What is the target price for Aldeyra Therapeutics (ALDX) stock?

The latest price target for Aldeyra Therapeutics (NASDAQ: ALDX) was reported by Oppenheimer on Monday, May 6, 2024. The analyst firm set a price target for 10.00 expecting ALDX to rise to within 12 months (a possible 153.81% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Aldeyra Therapeutics (ALDX)?

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $3.94 last updated Today at May 9, 2024 at 4:00 PM EDT.

Does Aldeyra Therapeutics (ALDX) pay a dividend?

There are no upcoming dividends for Aldeyra Therapeutics.

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

Aldeyra Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Aldeyra Therapeutics (ALDX) going to split?

There is no upcoming split for Aldeyra Therapeutics.

What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-